Contact

Our portfolio

ForceSense

ForceSense develops and sells the Lapron boxtrainer, a portable device for laparoscopic surgery training. Their integrated sensor system tracks performance and benchmarks it against a database. ForceSense’s technology allows for unsupervised, at-home surgical practice. The company is committed to enhancing surgical training through innovative simulation tools.

  • Institute: Amsterdam UMC
Industry: Simulation, Surgery
  • Founding year: 2010
Visit website

Want to get in contact about ForceSense?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

DCPrime
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
AviSia Therapeutics
Modulating immune responses with glycan-modified antigens for the treatment of Type 1 Diabetes.
Pepper Therapeutics
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Glass Medical AI
Stratifying patients for oncology trials with explainable AI on pathology data.
DCPrime
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
AviSia Therapeutics
Modulating immune responses with glycan-modified antigens for the treatment of Type 1 Diabetes.
Pepper Therapeutics
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Glass Medical AI
Stratifying patients for oncology trials with explainable AI on pathology data.
Explore full AAV portfolio
Contact